Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions

 April 17, 2026

Pharmaceutical Technology

Daiichi Sankyo has partnered with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor (MNM) technology.

M&A / DealsRead full story

Post navigation

Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director →
← Trump names Erica Schwartz to fill leadership void at CDC

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com